NASDAQ:EVFM

Evofem Biosciences News Headlines

$1.67
-0.02 (-1.18 %)
(As of 04/13/2021 10:33 AM ET)
Add
Compare
Today's Range
$1.63
Now: $1.67
$1.70
50-Day Range
$1.71
MA: $2.66
$4.62
52-Week Range
$1.65
Now: $1.67
$6.87
Volume35,482 shs
Average Volume4.63 million shs
Market Capitalization$138.82 million
P/E RatioN/A
Dividend YieldN/A
Beta0.07

Headlines

Evofem Biosciences (NASDAQ EVFM) News Headlines Today

SourceHeadline
Evofem Biosciences (NASDAQ:EVFM) Price Target Cut to $7.00Evofem Biosciences (NASDAQ:EVFM) Price Target Cut to $7.00
marketbeat.com - March 15 at 8:37 AM
Evofem Biosciences, Inc. (NASDAQ:EVFM) Receives Average Recommendation of "Buy" from AnalystsEvofem Biosciences, Inc. (NASDAQ:EVFM) Receives Average Recommendation of "Buy" from Analysts
americanbankingnews.com - April 2 at 5:30 AM
 Brokerages Anticipate Evofem Biosciences, Inc. (NASDAQ:EVFM) Will Announce Quarterly Sales of $2.02 Million Brokerages Anticipate Evofem Biosciences, Inc. (NASDAQ:EVFM) Will Announce Quarterly Sales of $2.02 Million
americanbankingnews.com - March 30 at 3:42 AM
Evofem Biosciences Announces Closing of Public Offering of Common StockEvofem Biosciences Announces Closing of Public Offering of Common Stock
finance.yahoo.com - March 29 at 7:32 PM
Evofem Bio secures $30M capital via equity raiseEvofem Bio secures $30M capital via equity raise
seekingalpha.com - March 27 at 12:36 AM
The Daily Biotech Pulse: Bristol-Myers Squibbs Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq DebutThe Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut
markets.businessinsider.com - March 25 at 8:22 AM
Evofem Biosciences Announces Pricing of $30 Million Public Offering of Common StockEvofem Biosciences Announces Pricing of $30 Million Public Offering of Common Stock
finance.yahoo.com - March 24 at 10:20 PM
Evofem Biosciences Announces Proposed Public Offering of Common StockEvofem Biosciences Announces Proposed Public Offering of Common Stock
finance.yahoo.com - March 24 at 5:20 PM
Evofem Biosciences DTC Campaign "Get Phexxi" Delivers Strong Initial ImpactEvofem Biosciences' DTC Campaign "Get Phexxi" Delivers Strong Initial Impact
finance.yahoo.com - March 17 at 8:28 AM
Evofem Biosciences Announces Publication in American Journal of Obstetrics and Gynecology of AMPREVENCE Study of EVO100 for Chlamydia and Gonorrhea PreventionEvofem Biosciences Announces Publication in American Journal of Obstetrics and Gynecology of AMPREVENCE Study of EVO100 for Chlamydia and Gonorrhea Prevention
finance.yahoo.com - March 16 at 9:44 AM
Thursday 3/11 Insider Buying Report: NRK, EVFMThursday 3/11 Insider Buying Report: NRK, EVFM
nasdaq.com - March 11 at 1:13 PM
EVFM Mar 2021 0.500 callEVFM Mar 2021 0.500 call
ca.finance.yahoo.com - March 11 at 8:13 AM
Evofem Biosciences Launches Phexxi: Will Peak Sales Surprise?Evofem Biosciences Launches Phexxi: Will Peak Sales Surprise?
seekingalpha.com - March 11 at 8:13 AM
Evofem Biosciences Inc (EVFM) CEO Saundra L Pelletier Bought $103,168 of SharesEvofem Biosciences Inc (EVFM) CEO Saundra L Pelletier Bought $103,168 of Shares
finance.yahoo.com - March 9 at 11:43 PM
Evofem Biosciences EPS misses by $0.14, misses on revenueEvofem Biosciences EPS misses by $0.14, misses on revenue
seekingalpha.com - March 7 at 12:05 AM
What Type Of Shareholders Make Up Evofem Biosciences, Inc.s (NASDAQ:EVFM) Share Registry?What Type Of Shareholders Make Up Evofem Biosciences, Inc.'s (NASDAQ:EVFM) Share Registry?
finance.yahoo.com - March 6 at 2:04 PM
ROCE Insights For Evofem BiosciencesROCE Insights For Evofem Biosciences
finance.yahoo.com - March 5 at 2:33 PM
Why Evofem Biosciences Stock Is Falling TodayWhy Evofem Biosciences Stock Is Falling Today
finance.yahoo.com - March 5 at 2:33 PM
Evofem Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate UpdateEvofem Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - March 4 at 6:31 PM
Evofem Biosciences to Present at H.C. Wainwright Global Life Sciences ConferenceEvofem Biosciences to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - February 23 at 9:12 AM
Evofem Biosciences to Report Fourth Quarter and Year-End 2020 Results and Provide Corporate Update on Thursday, March 4, 2021Evofem Biosciences to Report Fourth Quarter and Year-End 2020 Results and Provide Corporate Update on Thursday, March 4, 2021
finance.yahoo.com - February 18 at 8:57 AM
Evofem Biosciences Launches U.S. Direct-to-Consumer Campaign to Accelerate Awareness of Phexxi®, A Non-Hormonal Birth Control Option for WomenEvofem Biosciences Launches U.S. Direct-to-Consumer Campaign to Accelerate Awareness of Phexxi®, A Non-Hormonal Birth Control Option for Women
finance.yahoo.com - February 16 at 9:02 AM
Evofem Biosciences and NCODA Announce Collaboration to Educate Oncology Community about Phexxi®, A Non-Hormonal Birth Control Option for Women with CancerEvofem Biosciences and NCODA Announce Collaboration to Educate Oncology Community about Phexxi®, A Non-Hormonal Birth Control Option for Women with Cancer
finance.yahoo.com - February 4 at 9:45 AM
Evofem Biosciences Wins Business Intelligence Groups BIG Innovation Award 2021Evofem Biosciences Wins Business Intelligence Group's BIG Innovation Award 2021
finance.yahoo.com - January 12 at 10:49 AM
Evofem Biosciences to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual ConferenceEvofem Biosciences to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
finance.yahoo.com - December 21 at 11:54 AM
Evofem Biosciences Provides Update on Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and GonorrheaEvofem Biosciences Provides Update on Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea
finance.yahoo.com - December 17 at 7:24 AM
Is EVFM A Good Stock To Buy Now?Is EVFM A Good Stock To Buy Now?
finance.yahoo.com - December 12 at 7:27 PM
Evofem Biosciences Announces Orange Book Listing of Two U.S. Patents for Phexxi®Evofem Biosciences Announces Orange Book Listing of Two U.S. Patents for Phexxi®
finance.yahoo.com - December 11 at 8:07 AM
The U.S. Department of Veterans Affairs Awards Contract to Evofem Biosciences for Phexxi®The U.S. Department of Veterans Affairs Awards Contract to Evofem Biosciences for Phexxi®
finance.yahoo.com - December 3 at 2:08 PM
Evofem Biosciences to Participate in Piper Sandler 32nd Annual Virtual Healthcare ConferenceEvofem Biosciences to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference
finance.yahoo.com - November 20 at 9:30 AM
Evofem: The Race Between Revenue Ramp And Cash BurnEvofem: The Race Between Revenue Ramp And Cash Burn
seekingalpha.com - November 16 at 4:41 PM
Evofem Biosciences, Inc. 2020 Q3 - Results - Earnings Call PresentationEvofem Biosciences, Inc. 2020 Q3 - Results - Earnings Call Presentation
seekingalpha.com - November 12 at 4:22 PM
Evofem Biosciences to Present at Stifel Virtual Healthcare ConferenceEvofem Biosciences to Present at Stifel Virtual Healthcare Conference
finance.yahoo.com - November 12 at 2:14 PM
Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier On Q3 2020 Results - Quick Version Earnings Call TranscriptEvofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier On Q3 2020 Results - Quick Version Earnings Call Transcript
seekingalpha.com - November 9 at 11:56 PM
Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q3 2020 Results - Earnings Call TranscriptEvofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 9 at 11:56 PM
Evofem Biosciences, Inc. (EVFM) Q3 2020 Earnings Call TranscriptEvofem Biosciences, Inc. (EVFM) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 9 at 11:56 PM
Evofem Biosciences EPS beats by $0.07, misses on revenueEvofem Biosciences EPS beats by $0.07, misses on revenue
seekingalpha.com - November 9 at 6:56 PM
Evofem Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateEvofem Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - November 9 at 6:56 PM
Evofem Biosciences to Report Third Quarter 2020 Results and Provide Corporate Update on Monday, November 9, 2020Evofem Biosciences to Report Third Quarter 2020 Results and Provide Corporate Update on Monday, November 9, 2020
finance.yahoo.com - October 27 at 8:56 AM
Evofem Biosciences to Participate in Virtual Investor KOL RoundtableEvofem Biosciences to Participate in Virtual Investor KOL Roundtable
finance.yahoo.com - October 26 at 1:17 PM
Evofems Major Sell-Off Undervalues The Companys Long-Term PotentialEvofem's Major Sell-Off Undervalues The Company's Long-Term Potential
seekingalpha.com - October 21 at 5:18 PM
Evofem commences late-stage study of EVO100 for the prevention of STDs in womenEvofem commences late-stage study of EVO100 for the prevention of STDs in women
seekingalpha.com - October 20 at 10:25 AM
Evofem Biosciences Announces First Patient Enrolled in Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and GonorrheaEvofem Biosciences Announces First Patient Enrolled in Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea
finance.yahoo.com - October 20 at 10:25 AM
Evofem Biosciences trades high on $25M strategic investmentEvofem Biosciences trades high on $25M strategic investment
seekingalpha.com - October 15 at 8:23 AM
Evofem: Why I Bought Fridays Massive Spike DownEvofem: Why I Bought Friday's Massive Spike Down
seekingalpha.com - September 14 at 1:10 PM
Evofem Biosciences to Present Data at the 2020 STD Prevention Virtual Conference from Phase 2b Trial of EVO100 for Prevention of Chlamydia and Gonorrhea in WomenEvofem Biosciences to Present Data at the 2020 STD Prevention Virtual Conference from Phase 2b Trial of EVO100 for Prevention of Chlamydia and Gonorrhea in Women
finance.yahoo.com - September 14 at 1:10 PM
Is the Options Market Predicting a Spike in Evofem Biosciences (EVFM) Stock?Is the Options Market Predicting a Spike in Evofem Biosciences (EVFM) Stock?
finance.yahoo.com - September 14 at 1:10 PM
Return On Capital Employed Overview: Evofem BiosciencesReturn On Capital Employed Overview: Evofem Biosciences
benzinga.com - September 11 at 5:26 PM
Evofem Biosciences slumps after CEO sells sharesEvofem Biosciences slumps after CEO sells shares
seekingalpha.com - September 11 at 12:26 PM
Why Evofem Biosciences Is Trading Lower TodayWhy Evofem Biosciences Is Trading Lower Today
msn.com - September 11 at 12:26 PM
Why Evofem Biosciences Stock Is Plunging TodayWhy Evofem Biosciences Stock Is Plunging Today
finance.yahoo.com - September 11 at 12:26 PM
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.